Psychopharmacology and Psychiatry Updates

Un pódcast de Psychopharmacology Institute

Categorías:

247 Episodo

  1. The Power of Alliance in Psychopharmacology

    Publicado: 12/12/2024
  2. Antipsychotics in Youth: Balancing Metabolic Risk

    Publicado: 7/12/2024
  3. The Double-Edged Sword of Biological Explanations in Mental Health

    Publicado: 2/12/2024
  4. New Insights into Psychiatric and Cardiovascular Comorbidity

    Publicado: 27/11/2024
  5. Beyond the Pill: The Psychology of Psychopharmacology

    Publicado: 22/11/2024
  6. On Methylphenidate and Sleep: A Two-Year Study

    Publicado: 17/11/2024
  7. Nature's Pharmacy: Combining Natural Remedies in Psychiatry

    Publicado: 12/11/2024
  8. Breaking the Cycle: Memantine in Body-Focused Repetitive Behaviors

    Publicado: 7/11/2024
  9. The Potential of Ashwagandha in Psychiatry

    Publicado: 2/11/2024
  10. Treatment Dilemmas: ECT for Depressed Teens

    Publicado: 28/10/2024
  11. CBD in Psychiatry: Promise or Hype?

    Publicado: 23/10/2024
  12. Beyond Dopamine: Cannabidiol in Parkinson's Care

    Publicado: 18/10/2024
  13. Is NAC Promising in Bipolar and Depression Treatment?

    Publicado: 13/10/2024
  14. Microbes and the Mind: Probiotics and ADHD

    Publicado: 8/10/2024
  15. Lithium, Lamotrigine, and Labor: Managing Bipolar Disorder in Expectant Mothers

    Publicado: 3/10/2024
  16. Rethinking Haloperidol in Geriatric Delirium

    Publicado: 28/9/2024
  17. Antipsychotics in Pregnancy: A Balancing Act

    Publicado: 23/9/2024
  18. Risperidone in Youth Anorexia: A Promising Solution?

    Publicado: 18/9/2024
  19. Navigating Lithium: A Guide for Expectant Mothers with Bipolar Disorder

    Publicado: 13/9/2024
  20. DORA: A New Frontier in Insomnia Treatment

    Publicado: 8/9/2024

1 / 13

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site